Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Releasing the Cancer Patient's Immune System From Down-regulation With Timed Delivery of Standard Chemotherapy

NCT00568451 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00568451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00568451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Releasing the Cancer Patient's Immune System From Down-regulation With Timed Delivery of Standard Chemotherapy
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2006
Completion date
April 30, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)